<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Loss of <z:chebi fb="0" ids="50114">estrogen</z:chebi> receptor β (ERβ) expression in the gut is associated with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) initiation and progression </plain></SENT>
<SENT sid="1" pm="."><plain>Germline single-nucleotide polymorphisms (SNP) in genes for the sex-steroid hormone receptors are not strongly associated with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> risk; however, these SNPs have not previously been evaluated in relation to survival after diagnosis </plain></SENT>
<SENT sid="2" pm="."><plain>We enrolled 729 women, ages 50 to 74, diagnosed with invasive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> between 1997 and 2002 in 13 counties covered by the Seattle-Puget Sound Surveillance Epidemiology and End Results <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> registry </plain></SENT>
<SENT sid="3" pm="."><plain>Participants provided germline DNA </plain></SENT>
<SENT sid="4" pm="."><plain>We selected 99 tag-SNPs for the <z:chebi fb="3" ids="50113">androgen</z:chebi> receptor (AR), ERα (ESR1), ERβ (ESR2), and <z:chebi fb="28" ids="17026">progesterone</z:chebi> receptor (PGR) genes </plain></SENT>
<SENT sid="5" pm="."><plain>Mortality outcomes were ascertained from the National <z:hpo ids='HP_0011420'>Death</z:hpo> Index </plain></SENT>
<SENT sid="6" pm="."><plain>During a median of 6.6 years of follow-up, 244 <z:hpo ids='HP_0011420'>deaths</z:hpo> occurred (161 from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="7" pm="."><plain>We identified 20 SNPs (12 of ESR2 and 8 of PGR) for replication in 1,729 women diagnosed with incident invasive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> (555 <z:hpo ids='HP_0011420'>deaths</z:hpo>; 405 from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) from three prospective cohort studies that participate in the Genetics and Epidemiology of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal Cancer</z:e> Consortium </plain></SENT>
<SENT sid="8" pm="."><plain>Three correlated SNPs in the promoter of ESR2 (rs2987983, rs3020443, and rs2978381) were statistically significant predictors of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>-specific and overall survival </plain></SENT>
<SENT sid="9" pm="."><plain>Minor alleles of each were associated with improved survival [for rs2987983, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>-specific HR, 0.77; 95% confidence interval (CI), 0.60-0.99 in the initial study, and HR, 0.79; CI, 0.64-0.98 in replication] </plain></SENT>
<SENT sid="10" pm="."><plain>No associations were noted for SNPs of AR, ESR1, or PGR </plain></SENT>
<SENT sid="11" pm="."><plain>SNPs in the promoter of ESR2 may be important to pathways related to the association between ERβ and <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e> and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
</text></document>